drugset / Trial / NCT02688530

Intravenous Dexamethasone on Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy

NCT02688530 ↗

Phase 4 Completed 140 enrolled Hospital for Special Surgery, New York
RandomizedParallel-groupQuadruple-blindOther

Summary

Previous studies have confirmed that IV dexamethasone prolongs brachial plexus blocks. However, these studies only used fixed doses of IV dexamethasone at relatively high doses, which could potentially lead to increased glucose levels, delayed wound healing, and unintended side effects. There remains a paucity of research on the effective dose range of IV dexamethasone for the prolongation of supraclavicular blocks. The optimal dosage of IV dexamethasone for prolongation of analgesia vs. motor block prolongation from supraclavicular blocks in shoulder surgery has yet to be delineated.

Timeline

Start
2016-05
Primary completion
2017-11-19
Completion
2017-11-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg Intravenous
Subject Dexamethasone Small molecule 6 mg Intravenous
Subject Dexamethasone Small molecule 8 mg Intravenous

Indications

No indication recorded.